Skip to main content
logo
ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.470
+0.020 (1.38%)
Apr 8, 2026, 11:41 AM EDT - Market open

ABVC BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
3652892198
Market Cap Growth
303.59%568.36%-15.85%-55.15%-79.06%-21.27%
Enterprise Value
38.5655.68.0110.0823.294.92
Last Close Price
1.472.130.591.166.2533.90
PE Ratio
--5.46-1.40-0.64-1.20-66.47
PS Ratio
--15.2160.4321.18275.61
PB Ratio
3.174.666.325.936.6311.09
P/TBV Ratio
2.703.865.62-6.3912.14
P/FCF Ratio
--17.35-4.28-2.19-2.73-12.88
P/OCF Ratio
--17.35-4.28-2.20-2.78-12.91
EV/Sales Ratio
--15.7266.1123.92266.77
EV/EBITDA Ratio
--7.80-1.71-1.50-1.54-8.12
EV/EBIT Ratio
--7.78-1.70-1.49-1.53-8.11
EV/FCF Ratio
--18.62-4.43-2.39-3.09-12.46
Debt / Equity Ratio
0.180.181.491.040.830.31
Debt / EBITDA Ratio
-0.44-0.49-0.52-0.38-0.20-0.27
Debt / FCF Ratio
-1.16-1.16-1.34-0.62-0.41-0.41
Net Debt / Equity Ratio
0.250.251.731.580.93-0.32
Net Debt / EBITDA Ratio
-0.34-0.38-0.45-0.36-0.190.24
Net Debt / FCF Ratio
-0.91-0.91-1.17-0.58-0.380.37
Asset Turnover
-00.070.020.080.03
Inventory Turnover
----22.050.39
Quick Ratio
0.240.240.220.150.281.72
Current Ratio
0.410.410.330.270.542.07
Return on Equity (ROE)
-130.84%-119.49%-531.91%-368.89%-269.48%-208.73%
Return on Assets (ROA)
-55.73%-50.15%-60.14%-80.43%-136.54%-99.33%
Return on Invested Capital (ROIC)
-80.21%-72.18%-117.95%-131.68%-245.06%-215.71%
Return on Capital Employed (ROCE)
-100.09%-90.06%-353.11%-236.66%-215.28%-139.62%
Earnings Yield
-22.07%-18.31%-71.19%-155.17%-83.04%-1.50%
FCF Yield
-8.33%-5.76%-23.34%-45.69%-36.61%-7.77%
Buyback Yield / Dilution
-72.25%-72.25%--0.00%-60.61%
Total Shareholder Return
-72.25%-72.25%--0.00%-60.61%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q